Skip to main content
Top
Literature
1.
go back to reference Coutts AA, Izzo AA (2004) The gastrointestinal pharmacology of cannabinoids: an update. Curr Opin Pharmacol 4:572–579PubMedCrossRef Coutts AA, Izzo AA (2004) The gastrointestinal pharmacology of cannabinoids: an update. Curr Opin Pharmacol 4:572–579PubMedCrossRef
2.
go back to reference Coruzzi G, Adami M, Guaita E, Menozzi A, Bertini S, Giovannini E, Soldani G (2006) Effects of cannabinoid receptor agonists on rat gastric acid secretion: discrepancy between in vitro and in vivo data. Dig Dis Sci 51:310–317PubMedCrossRef Coruzzi G, Adami M, Guaita E, Menozzi A, Bertini S, Giovannini E, Soldani G (2006) Effects of cannabinoid receptor agonists on rat gastric acid secretion: discrepancy between in vitro and in vivo data. Dig Dis Sci 51:310–317PubMedCrossRef
3.
go back to reference Horie S, Maruyama T, Yano S, Watanabe K (1996) Neurogenic stimulation of gastric acid secretion by the Na+, K(+)-ATPase inhibitor ouabain in mouse isolated stomach. Gen Pharmacol 27:905–909PubMed Horie S, Maruyama T, Yano S, Watanabe K (1996) Neurogenic stimulation of gastric acid secretion by the Na+, K(+)-ATPase inhibitor ouabain in mouse isolated stomach. Gen Pharmacol 27:905–909PubMed
4.
go back to reference Izzo AA, Mascolo N, Capasso F (2001) The gastrointestinal pharmacology of cannabinoids. Curr Opin Pharmacol 1:597–603PubMedCrossRef Izzo AA, Mascolo N, Capasso F (2001) The gastrointestinal pharmacology of cannabinoids. Curr Opin Pharmacol 1:597–603PubMedCrossRef
5.
go back to reference Halford JC (2006) Obesity drugs in clinical development. Curr Opin Investig Drugs 7:312–318PubMed Halford JC (2006) Obesity drugs in clinical development. Curr Opin Investig Drugs 7:312–318PubMed
6.
Metadata
Title
Cannabinoid CB1 Receptor and Gastric Acid Secretion
Author
Francesca Borrelli
Publication date
01-11-2007
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 11/2007
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-006-9507-4

Other articles of this Issue 11/2007

Digestive Diseases and Sciences 11/2007 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.